These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Promote multidisciplinary study on anthracycline-induced cardiotoxicity in children]. Chen SB; Huang MR; Tang JY Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):565-8. PubMed ID: 24225284 [No Abstract] [Full Text] [Related]
3. [Management of cardiovascular complications secondary to medical treatment of cancer]. Banke A; Polk A; Nielsen D; Videbæk L; Overgaard U; Fosbøl EL; Vaage-Nielsen M; Nielsen KM; Schou M Ugeskr Laeger; 2018 Feb; 180(7):. PubMed ID: 29465031 [TBL] [Abstract][Full Text] [Related]
4. [Control of cardiac function during therapy with doxorubicin and other anthracyclines]. Grille W; Johnsen K; Kolenda KD; Schöttler M; Löffler H Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1134-7. PubMed ID: 3859399 [No Abstract] [Full Text] [Related]
5. [Cardioxan: prevention of anthracycline-related cardiotoxicity]. Gershanovich ML Vopr Onkol; 2004; 50(4):482-91. PubMed ID: 15605776 [No Abstract] [Full Text] [Related]
6. [Cardiac pathology in patients after therapy for Hodgkin's lymphoma]. Danilenko AA; Shakhtarina SV Vopr Onkol; 2011; 57(1):119-25. PubMed ID: 21598720 [No Abstract] [Full Text] [Related]
7. [Chemotherapy-induced cardiac toxicity and management]. Komagata H; Sakai H Gan To Kagaku Ryoho; 2003 Jun; 30(6):787-92. PubMed ID: 12852345 [TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity of doxorubicin and other anthracycline derivatives. Jain D J Nucl Cardiol; 2000; 7(1):53-62. PubMed ID: 10698235 [No Abstract] [Full Text] [Related]
9. Pathogenesis of cardiotoxicity induced by anthracyclines. Elliott P Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283 [TBL] [Abstract][Full Text] [Related]
11. [Is cardiotoxicity of chemotherapy a problem of the oncologist or also the cardiologist?]. Pudil R; Horácek JM Vnitr Lek; 2006 Apr; 52(4):306-7. PubMed ID: 16755985 [No Abstract] [Full Text] [Related]
12. The cardiotoxicity of anticancer agents. Von Hoff DD; Rozencweig M; Piccart M Semin Oncol; 1982 Mar; 9(1):23-33. PubMed ID: 7071608 [TBL] [Abstract][Full Text] [Related]
13. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy]. Svojgrová M; Slechtová J; Hůla J Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075 [TBL] [Abstract][Full Text] [Related]
14. Anthracycline cardiotoxicity, no longer an issue? Green M Ann Oncol; 1998 Jul; 9(7):691-3. PubMed ID: 9739432 [No Abstract] [Full Text] [Related]
15. Cardiac safety of liposomal anthracyclines. Batist G Cardiovasc Toxicol; 2007; 7(2):72-4. PubMed ID: 17652807 [TBL] [Abstract][Full Text] [Related]
16. [High-resolution electrocardiography in monitoring myocardial damage after therapy with anthracyclines in children]. Mladosievicová B; Foltinová A; Bernadic M; Petrásová H; Hulín I Bratisl Lek Listy; 1996 May; 97(5):289-97. PubMed ID: 8705327 [TBL] [Abstract][Full Text] [Related]
17. Cancer and the heart. Dobson R; Wright DJ Br J Gen Pract; 2018 May; 68(670):220-221. PubMed ID: 29700020 [No Abstract] [Full Text] [Related]
18. [Prevention of cardiotoxic effects of anthracyclines in oncopediatric praxis]. Safonova SA; Gershanovich ML; Punanov IuA Vopr Onkol; 2006; 52(5):590-2. PubMed ID: 17168373 [No Abstract] [Full Text] [Related]
19. Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes. Gianni L; Salvatorelli E; Minotti G Cardiovasc Toxicol; 2007; 7(2):67-71. PubMed ID: 17652806 [TBL] [Abstract][Full Text] [Related]
20. Patients undergoing cancer treatments need monitoring to prevent heart injuries. Health News; 2004 Nov; 10(11):9. PubMed ID: 15655855 [No Abstract] [Full Text] [Related] [Next] [New Search]